These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18466962)

  • 1. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies.
    Johnson PM; Hollander JA; Kenny PJ
    Pharmacol Biochem Behav; 2008 Sep; 90(3):409-15. PubMed ID: 18466962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
    Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
    Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
    Stoker AK; Olivier B; Markou A
    Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from repeated nicotine vapor exposure increases somatic signs of physical dependence, anxiety-like behavior, and brain reward thresholds in adult male rats.
    Martínez M; Espinoza VE; Garcia V; Uribe KP; Negishi K; Estevao IL; Carcoba LM; O'Dell LE; Khan AM; Mendez IA
    Neuropharmacology; 2023 Dec; 240():109681. PubMed ID: 37611823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
    Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.
    Stoker AK; Semenova S; Markou A
    Neuropharmacology; 2008 Jun; 54(8):1223-32. PubMed ID: 18452957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.
    Stoker AK; Olivier B; Markou A
    Psychopharmacology (Berl); 2012 May; 221(2):317-27. PubMed ID: 22147259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.
    Stoker AK; Marks MJ; Markou A
    Eur J Pharmacol; 2015 Apr; 753():146-50. PubMed ID: 25107281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats.
    Qi X; Guzhva L; Ji Y; Bruijnzeel AW
    Behav Brain Res; 2015 Oct; 292():259-65. PubMed ID: 26112757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
    Rylkova D; Boissoneault J; Isaac S; Prado M; Shah HP; Bruijnzeel AW
    Neuropeptides; 2008 Jun; 42(3):215-27. PubMed ID: 18468678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.
    Marcinkiewcz CA; Prado MM; Isaac SK; Marshall A; Rylkova D; Bruijnzeel AW
    Neuropsychopharmacology; 2009 Jun; 34(7):1743-52. PubMed ID: 19145226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
    Bruijnzeel AW; Prado M; Isaac S
    Biol Psychiatry; 2009 Jul; 66(2):110-7. PubMed ID: 19217073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.
    Shram MJ; Siu EC; Li Z; Tyndale RF; Lê AD
    Psychopharmacology (Berl); 2008 Jun; 198(2):181-90. PubMed ID: 18385986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
    Harris AC; Manbeck KE; Schmidt CE; Shelley D
    Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.
    Qi X; Guzhva L; Yang Z; Febo M; Shan Z; Wang KKW; Bruijnzeel AW
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1378-1389. PubMed ID: 27461514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
    Watkins SS; Stinus L; Koob GF; Markou A
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal.
    Qi X; Shan Z; Ji Y; Guerra V; Alexander JC; Ormerod BK; Bruijnzeel AW
    Transl Psychiatry; 2014 Apr; 4(4):e385. PubMed ID: 24755994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.
    Hilario MR; Turner JR; Blendy JA
    Neuropsychopharmacology; 2012 Nov; 37(12):2661-70. PubMed ID: 22828747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further pharmacological characterization of a preclinical model of the early development of nicotine withdrawal.
    Harris AC
    Drug Alcohol Depend; 2021 Sep; 226():108870. PubMed ID: 34216863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.